Chinese Stocks To Research – August 9th

Posted by on Aug 9th, 2026

Diageo, UP Fintech, RBB Bancorp, China SXT Pharmaceuticals, and Regencell Bioscience are the five Chinese stocks to watch today, according to MarketBeat’s stock screener tool. “Chinese stocks” refers to shares of companies based in China or whose business is substantially tied to the Chinese economy. Investors may access them through mainland exchanges, Hong Kong-listed shares, or overseas-listed securities such as American depositary receipts (ADRs), each of which can involve different regulations, market access, and risks. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.

Diageo (DEO)

Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.

Read Our Latest Research Report on DEO

UP Fintech (TIGR)

UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.

Read Our Latest Research Report on TIGR

RBB Bancorp (RBB)

RBB Bancorp operates as the bank holding company for Royal Business Bank that provides various banking products and services to the Chinese-American, Korean-American, and other Asian-American communities. Its deposit products include checking, savings, and money market accounts, as well as certificates of deposit.

Read Our Latest Research Report on RBB

China SXT Pharmaceuticals (SXTC)

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

Read Our Latest Research Report on SXTC

Regencell Bioscience (RGC)

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.

Read Our Latest Research Report on RGC

Read More